BUSINESS NEWS

Storm Clouds Continue to Gather Over Canada’s Economy· EnergyNow Mark Carney pitches Canada to global investors amid US trade war· Al Jazeera How Carney plans to sell Canada to the world's biggest investors· BBC Ottawa offers faster access to tax rulings as Carney kicks off investment summit· BNN Bloomberg Look West: Jobs and Prosperity for a Stronger BC and Canada - Province of British Columbia· gov.bc.ca What will Trump's retaliatory tariffs do to Canada’s economy big picture? Not that much, economists predict· CBC Three city summit set to discuss Canadian food economy· 🇨🇦 Grocery Business Canada Carney to showcase Canada’s capital agenda at first-ever investment summit· CityNews Toronto BMO targets Canada’s next era of growth with commitment of up to $70 billion for critical economic sectors· BMO Chinese ambassador to Canada shows interest in First Nations investments in B.C.· Business in Vancouver Canada’s economy rebounded strongly in Q2 as domestic demand strengthened· rbc.com Carney says economic activity already spurring from investment summit - National· Global News End of USMCA would be ‘severe but not cataclysmic’ for Canada’s economy, Deloitte says· The Globe and Mail Triggering a Canadian Investment Supercycle· TD Economics Carney teases economic activity already spurring from investment summit· BNN Bloomberg

← All tenders

Department of Public Works and Government Services (PSPC)

ACAN Vaccinia Immunoglobulin intravenous (human) - VIGIV

Name: ACAN Vaccinia Immunoglobulin intravenous (human) - VIGIV
Creator: Department of Public Works and Government Services (PSPC)

Other

Estimated value

Not disclosed

Deadline

September 30, 2026

Published

September 10, 2026

Type

Goods

Full description

Advanced Contract Award Notice(ACAN) - Vaccinia Immunoglobulin intravenous (human) (VIGIV)
An ACAN is a public notice indicating to the supplier community that a department or agency intends to award a contract for goods, services or construction to a pre-identified supplier, thereby allowing other suppliers to signal their interest in bidding, by submitting a statement of capabilities. If no supplier submits a statement of capabilities that meets the requirements set out in the ACAN, on or before the closing date stated in the ACAN, the contracting officer may then proceed with the award to the pre identified supplier.
Purpose of this Advanced Contract Award Notice (ACAN):
Public Services and Procurement Canada proposes to negotiate a contract with Emergent BioSolutions Canada Inc on behalf of Public Health Agency of Canada (PHAC).
Requirement description:
Public Health Agency of Canada (PHAC) has a requirement for vaccinia Immunoglobulin intravenous (human) (VIGIV) to protect against complications from vaccination with live-replicating smallpox vaccines containing vaccinia virus.

Selection criteria

Not applicable

AI Summary

Advanced Contract Award Notice(ACAN) - Vaccinia Immunoglobulin intravenous (human) (VIGIV) An ACAN is a public notice indicating to the supplier community that a department or agen...

AI Analysis

Get a plain-English breakdown of this tender — what they need, who can bid, how to approach it, and tips for small suppliers. Takes a couple of seconds.

Basic information

Reference

WS5872093541-Doc5872241906

Solicitation no.

WS5872093541

Buyer

Department of Public Works and Government Services (PSPC)

Notice type

Advance Contract Award Notice

Method

Advance contract award notice

Procurement category

*GD

Trade agreements

*Canada-Colombia Free Trade Agreement *Canada-Peru Free Trade Agreement (CPFTA) *Canada-UK Trade Continuity Agreement (Canada-UK TCA) *World Trade Organization Agreement on Government Procurement (WTO GPA) *Canada-Chile Free Trade Agreement (CCFTA) *Canada-European Union Comprehensive Economic and Trade Agreement (CETA) *Canada-Ukraine Free Trade Agreement (CUFTA) *Canada-Korea Free Trade Agreement (CKFTA) *Canada-Panama Free Trade Agreement *Comprehensive and Progressive Agreement for Trans-Pacific Partnership (CPTPP) *Canada-Honduras Free Trade Agreement *Canadian Free Trade Agreement (CFTA)

Estimated value

Not disclosed

Source

canadabuys

Classification & terms

UNSPSC

UNSPSC 51000000 — Drugs and Pharmaceutical Products

Limited tendering reason

Exclusive Rights

Delivery & regions

Province

Quebec

Regions of delivery

*Canada

Key dates

Published

September 10, 2026

Closes

September 30, 2026

Amendment no.

000

Amendment date

September 10, 2026

Contact

Contact

R••••••••, A••• (S•••/P•••)

Email

a••••••••@••••••••.••.ca

Address

•• ••••••• ••, ••••• •••, ••••• •• •••••••, ••••••••, ••••••, ••• •••, ••••••

End-user

Public Health Agency of Canada (PHAC)

Likely incumbents

(5)

Suppliers who have won similar work from this buyer before.

1
BOEHRINGER INGELHEIM ANIMAL HEALTH
2 contracts won· latest May 28, 2025
CAD $36.2M
total awarded
2
Moderna Biopharma Canada Corporation
1 contract won· latest June 30, 2025
CAD $360.5M
total awarded
3
Pfizer Canada ULC
1 contract won· latest January 25, 2023
CAD $39.5M
total awarded
4
SANOFI PASTEUR LIMITED/SANOFI PASTEUR LIMITEE
1 contract won· latest March 30, 2026
CAD $37.8M
total awarded
5
Emergent Product Development Gaithersburg Inc
1 contract won· latest February 25, 2026
CAD $34.2M
total awarded

BOEHRINGER INGELHEIM ANIMAL HEALTH is the most likely incumbent, based on how often and how recently they have won this buyer’s work in this category. To displace them, expect to need a clearly stronger proposition or price.

Complete source record(28)

Title

ACAN Vaccinia Immunoglobulin intravenous (human) - VIGIV

Reference number

WS5872093541-Doc5872241906

Amendment number

000

Solicitation number

WS5872093541

Publication date

2026-09-10

Tender closing date

2026-09-30T14:00:00

Amendment date

2026-09-10

Tender status

Open

Unspsc

*51000000

Unspsc description

*Drugs and Pharmaceutical Products

Procurement category

*GD

Notice type

Advance Contract Award Notice

Procurement method

Advance contract award notice

Selection criteria

Not applicable

Limited tendering reason

Exclusive Rights

Trade agreements

Regions of delivery

*Canada

Contracting entity name

Department of Public Works and Government Services (PSPC)

Contracting entity address line

11 Laurier St, Phase III, Place du Portage

Contracting entity address city

Gatineau

Contracting entity address province

Quebec

Contracting entity address postal code

K1A 0S5

Contracting entity address country

Canada

End user entities name

Public Health Agency of Canada (PHAC)

End user entities address

130 Colonnade Road,Ottawa,Ontario,K1A 0K9,Canada

Contact info name

R••••••••, A••• (S•••/P•••)

Contact info email

a••••••••@••••••••.••.ca

Tender description

Advanced Contract Award Notice(ACAN) - Vaccinia Immunoglobulin intravenous (human) (VIGIV) An ACAN is a public notice indicating to the supplier community that a department or agency intends to award a contract for goods, services or construction to a pre-identified supplier, thereby allowing other suppliers to signal their interest in bidding, by submitting a statement of capabilities. If no supplier submits a statement of capabilities that meets the requirements set out in the ACAN, on or before the closing date stated in the ACAN, the contracting officer may then proceed with the award to the pre identified supplier. Purpose of this Advanced Contract Award Notice (ACAN): Public Services and Procurement Canada proposes to negotiate a contract with Emergent BioSolutions Canada Inc on behalf of Public Health Agency of Canada (PHAC). Requirement description: Public Health Agency of Canada (PHAC) has a requirement for vaccinia Immunoglobulin intravenous (human) (VIGIV) to protect against complications from vaccination with live-replicating smallpox vaccines containing vaccinia virus.